Progyny, Inc. (PGNY) は上場企業です ヘルスケア セクターの Medical - Healthcare Information Services 業界で事業展開. 本社所在地は New York City, NY, アメリカ. 現CEOは Peter Anevski.
PGNY を有する IPO日 2019-10-25, 675 名の正社員, に上場 NASDAQ Global Select, 時価総額 $1.41B.
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
